Fri, January 4, 2019
Thu, January 3, 2019
Wed, January 2, 2019

Jack Meehan Upgraded (BIO) to Buy and Held Target at $315 on, Jan 3rd, 2019

Jack Meehan of Barclays, Upgraded "Bio-Rad Laboratories, Inc." (BIO) to Buy and Held Target at $315 on, Jan 3rd, 2019.

Jack has made no other calls on BIO in the last 4 months.



There are 2 other peers that have a rating on BIO. Out of the 2 peers that are also analyzing BIO, 1 agrees with Jack's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Steve Beuchaw of "Morgan Stanley" Initiated at Hold and Held Target at $335 on, Thursday, September 20th, 2018


This is the rating of the analyst that currently disagrees with Jack


  • Patrick Donnelly of "Goldman Sachs" Initiated at Strong Buy and Held Target at $350 on, Wednesday, October 17th, 2018